A novel prognostic tool, the Weighted Alpha-Fetoprotein Tumor Burden Score (WATS), has demonstrated enhanced predictive capabilities for hepatocellular carcinoma patients post-resection. In a study involving 772 patients, WATS outperformed existing staging systems, offering reliable assessments of progression-free survival and overall survival across various time frames. Its formula incorporates tumor number, size, and alpha-fetoprotein levels, providing a significant advancement in patient stratification and clinical management, as evidenced by excellent discrimination and calibration results.
Journal Article by Lu T, Xie K (…) Xu F et 5 al. in Eur J Surg Oncol
Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.